---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-236516"
form_type: "8-K"
ticker: "RVMD"
cik: "0001628171"
company_name: "Revolution Medicines, Inc."
filed_at: "2022-09-01T23:59:59+00:00"
generated_at: "2026-06-23T17:34:57.339953+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Revolution Medicines promotes Jack Anders to CFO effective Sept 1, 2022

## Summary
- Jack Anders, age 45, appointed CFO effective immediately; previously SVP Finance and Principal Financial and Accounting Officer.
- Anders joined Revolution Medicines in August 2018; prior roles at Depomed (VP Finance), Elan Pharmaceuticals, Yahoo!, and Novellus Systems.
- He began his career at PricewaterhouseCoopers and holds a B.A. in Economics from UCLA; formerly a CPA.
- Anders will continue as Principal Financial and Accounting Officer; no departure of prior CFO announced.

## SEC filing metadata
- accession: 0001193125-22-236516
- form_type: 8-K
- ticker: RVMD
- cik: 0001628171
- company_name: Revolution Medicines, Inc.
- filed_at: 2022-09-01T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1628171/000119312522236516/0001193125-22-236516-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1628171/000119312522236516/d393123d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-236516
- JSON: https://secwatch.observer/filing/0001193125-22-236516.json
- Plain text: https://secwatch.observer/filing/0001193125-22-236516.txt

## Key facts
- Executive change
  Jack Anders changed role as Chief Financial Officer at Revolution Medicines, Inc..
  - Action: promoted
  - Role: Chief Financial Officer
  source text: On September 1, 2022, the Board of Directors (the “Board”) of Revolution Medicines, Inc. (the “Company”) promoted Jack Anders, age 45, to serve as the Chief Financial Officer of the Company, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1628171/000119312522236516/0001193125-22-236516-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.